Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
kochhar bd
(1 results)?
Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data.
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2427-2429.e1. doi: 10.1016/j.cgh.2023.03.040. Epub 2023 Apr 7.
Clin Gastroenterol Hepatol. 2023.
PMID: 37031712
No abstract available.
Emerging approaches to polypharmacy among older adults.
Mehta RS, Kochar BD, Kennelty K, Ernst ME, Chan AT.
Mehta RS, et al. Among authors: kochar bd.
Nat Aging. 2021 Apr;1(4):347-356. doi: 10.1038/s43587-021-00045-3. Epub 2021 Mar 22.
Nat Aging. 2021.
PMID: 37117591
Review.
Item in Clipboard
Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.
Kochar BD, Cheng D, Cai T, Ananthakrishnan AN.
Kochar BD, et al.
Dig Dis Sci. 2022 Nov;67(11):5206-5212. doi: 10.1007/s10620-022-07404-z. Epub 2022 Feb 3.
Dig Dis Sci. 2022.
PMID: 35113275
Item in Clipboard
Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases.
Cheng D, Kochar BD, Cai T, Ananthakrishnan AN.
Cheng D, et al. Among authors: kochar bd.
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2366-2372.e6. doi: 10.1016/j.cgh.2022.01.013. Epub 2022 Jan 20.
Clin Gastroenterol Hepatol. 2022.
PMID: 35066137
Free PMC article.
Item in Clipboard
Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.
Kochar BD, Cai W, Ananthakrishnan AN.
Kochar BD, et al.
Dig Dis Sci. 2022 Feb;67(2):622-628. doi: 10.1007/s10620-021-06990-8. Epub 2021 May 1.
Dig Dis Sci. 2022.
PMID: 33932198
Free PMC article.
Item in Clipboard
Cite
Cite